Company profile for VantAI

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, a...
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
New York, NY 10003
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240522594098/en

BUSINESSWIRE
22 May 2024

https://www.businesswire.com/news/home/20240508836921/en

BUSINESSWIRE
08 May 2024

https://www.businesswire.com/news/home/20240501342555/en

BUSINESSWIRE
01 May 2024
BMS signs $674M biobucks pact with VantAI for molecular glues
BMS signs $674M biobucks pact with VantAI for molecular glues

13 Feb 2024

// Gabrielle Masson FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/bms-and-roivants-vantai-go-after-molecular-glues-new-674m-deal

Gabrielle Masson FIERCE BIOTECH
13 Feb 2024

https://www.businesswire.com/news/home/20240207412121/en

BUSINESSWIRE
07 Feb 2024

https://www.businesswire.com/news/home/20240108659035/en

BUSINESSWIRE
09 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty